Antoniotti C, Boccaccino A, Seitz R, Giordano M, et al. An immune-related gene expression signature predicts benefit from adding atezolizumab to FOLFOXIRI plus bevacizumab in metastatic colorectal cancer. Clin Cancer Res 2023 Apr 6:CCR-22-3878. doi: 10.1158/1078-0432.CCR-22-3878.
PMID: 37022350